Target intelligence / Profile preview

Ribosomal protein S12 pseudogene 28 (RPS12P28)

Target
RPS12P28
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein S12 pseudogene 28 (RPS12P28) is a processed pseudogene, and not a functional protein-coding gene. Pseudogenes like RPS12P28 are nonfunctional segments of genomic DNA that are similar to normal genes but have lost their protein-coding ability through mutations or truncations. RPS12P28 is related in sequence to the functional ribosomal protein S12 gene, but as a pseudogene, it does not produce a functional protein product and does not have known biological functions, therapeutic relevance, or associated drugs. Pseudogenes are common in the human genome, especially for highly conserved proteins such as ribosomal proteins. They can arise through gene duplication or retrotransposition, and while they may be transcribed in some cases, they generally do not encode proteins and are not considered valid drug targets. The canonical ribosomal protein S12 (RPS12) is a component of the small ribosomal subunit and is involved in translation, but RPS12P28 is a pseudogene only related by sequence homology. There is no evidence or reporting that pseudogene RPS12P28 is implicated in any disease, is functionally expressed, or is used as a biomarker or therapeutic target. This entry is primarily for gene annotation and genomic reference—not a functional or druggable molecular target.

Other names
RPS12_14_1532RPS12P28

Beyond the preview

Go deeper on Ribosomal protein S12 pseudogene 28 (RPS12P28).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein S12 pseudogene 28 (RPS12P28).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call